| Catalog | name | Description | price |
|---|---|---|---|
| R-C-1497 | SKF96365 CAS:130495-35-1 | SKF96365,originally identified as a blocker of receptor-mediated calcium entry, is widely used diagnostically,as a blocker of transient receptor potential canonical type(TRPC)channels. | price> |
| R-C-1589 | SB 366791 CAS:472981-92-3 | SB-366791 is a potent,competitive and selective vanilloid receptor(VR1/TRPV1) antagonist with IC50 of 5.7±1.2 nM target:VR1/TRPV1 IC 50:5.7±1.2 nM[1] SB-366791 produced a concentration-dependent inhibition of the response to capsaicin with an apparent pKb of 7.74±0.08. | price> |
| R-C-1666 | NQ301 CAS:130089-98-4 | NQ301(Compound 211),an antiplatelet and antithrombotic agent,is a selective CD45 inhibitor with IC50 of 200 nM.NQ301 inhibits thromboxane A2 receptor(TXA2)and synthase activity in rabbit platelets. | price> |
| R-C-1700 | Lesinurad CAS: 878672-00-5 | Lesinurad is a URAT1 and OAT inhibitor,is determined to be a substrate for the kidney transporters OAT1 and OAT3 with Km values of 0.85 and 2µM, respectively. | price> |
| R-C-1747 | Verinurad (RDEA3170) CAS:1352792-74-5 | Verinurad(RDEA3170)is a high-affinity inhibitor of the URAT1 transporter with an IC50 of 25 nM for inhibiting transport activity of human URAT1.It inhibits the related URAT1 homologs OAT4 and OAT1 with approximately 200-fold lower affinity compared to URAT1 with IC50 values of 5.9µM and 4.6µM,respectively. | price> |
| R-C-1801 | BTB06584 CAS:219793-45-0 | BTB06584 is a selective and IF1-dependent mitochondrial F1Fo-ATPase inhibitor without compromising ATP synthesis.BTB06584 can delays ischaemic cell death. | price> |
| R-C-1811 | GSK2981278 CAS:1474110-21-8 | GSK2981278 is a potent and selective RORγ inverse agonist.GSK2981278 inhibits activation of the il17 promoter and interferes RORγ-DNA binding. | price> |
| R-C-1960 | GLPG1837 CAS:1654725-02-6 | GLPG-1837(ABBV-974)is a novel cystic fibrosis transmembrane conductance regulator(CFTR)potentiator1.GLPG1837 was generally safe and well tolerated in healthy subjects up to the highest dose of 800 mg twice daily for 2 weeks. GLPG1837 shows enhanced efficacy on CFTR mutants harboring Class III mutations compared to Ivacaftor,the first marketed potentiator. | price> |
| R-C-2000 | SR1078 CAS:1246525-60-9 | SR1078 is an agonist of retinoic acid receptor-related orphan receptors(ROR) RORα/γ;increases transcription of RORα target genes;thought to increase p53 stability. | price> |
| R-C-2009 | LIT-927 CAS:2172879-52-4 | LIT-927 is a Locally and Orally Active CXCL12 Neutraligand with Anti-inflammatory Effect in a Murine Model of Allergic Airway Hypereosinophilia. displays a higher solubility.LIT-927 reduces eosinophil recruitment in a murine model of allergic airway hypereosinophilia. | price> |

Items-$0.00

Email:
Tel.:
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


